BMRN

BioMarin Pharmaceutical Inc

BMRN · CIK 1048477 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$3.2B
20182025
Net Income$0.3B
20182025
Operating CF$0.8B
20182025
Free Cash Flow$0.7B
20182025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Revenue$3.2B$2.9B$2.4B$2.1B$1.8B$1.9B$1.7B$1.5B
Cost of Revenue$0.7B$0.6B$0.5B$0.5B$0.5B$0.5B$0.4B$0.3B
Gross Profit
R&D Expense$0.9B$0.7B$0.7B$0.6B$0.6B$0.6B$0.7B$0.7B
SG&A Expense$1.2B$1.0B$0.9B$0.9B$0.8B$0.7B$0.7B$0.6B
Operating Income$0.4B$0.5B$0.2B$0.1B$-0.1B$-0.0B$-0.1B$-0.1B
Net Income$0.3B$0.4B$0.2B$0.1B$-0.1B$0.9B$-0.0B$-0.1B
EPS (Basic)$1.82$2.25$0.89$0.76$-0.35$4.75$-0.13$-0.44
EPS (Diluted)$1.80$2.21$0.87$0.75$-0.35$4.53$-0.13$-0.44

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Total Assets$7.6B$7.0B$6.8B$6.4B$6.0B$5.8B$4.7B$4.4B
Current Assets$4.0B$3.2B$3.0B$2.8B$2.3B$2.3B$1.9B$2.1B
Cash & Equivalents$1.3B$0.9B$0.8B$0.7B$0.6B$0.6B$0.4B$0.5B
Total Liabilities$1.5B$1.3B$1.9B$1.8B$1.7B$1.7B$1.6B$1.5B
Current Liabilities$0.8B$0.6B$1.2B$0.6B$0.5B$0.5B$0.9B$0.5B
Stockholders' Equity$6.1B$5.7B$5.0B$4.6B$4.3B$4.1B$3.1B$3.0B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Operating Cash Flow$0.8B$0.6B$0.2B$0.2B$0.3B$0.1B$0.0B$0.0B
Investing Cash Flow$-0.4B$0.1B$-0.1B$-0.0B$-0.4B$-0.1B$-0.0B$0.3B
Capital Expenditures$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Financing Cash Flow$-0.0B$-0.5B$-0.0B$-0.0B$-0.0B$0.2B$-0.1B$-0.4B